167
Views
43
CrossRef citations to date
0
Altmetric
Review

Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold

&
Pages 3575-3590 | Published online: 01 Nov 2016

References

  • WHOWorld Malaria ReportGenevaWHO2015
  • RoySChetiaDRudrapalMPrakashASynthesis and antimalarial activity study of some new Mannich bases of 7-chloro-4-aminoquinolineMed Chem20139337938322946532
  • RudrapalMChetiaDPrakashASynthesis, antimalarial and antibacterial activity evaluation of some new 4-aminoquonoline derivativesMed Chem Res201322837033711
  • WarrellDACerebral malariaSchweiz Med Wochenschr1992122238798861615297
  • RidleyRJMedical need, scientific opportunity and the drive for antimalarial drugsNature200241568669311832957
  • FarooqUMahajanRCDrug resistance in malariaJ Vector Borne Dis2004413–4455315672556
  • WinstanleyPAWardSASnowRWClinical status and implications of antimalarial drug resistanceMicrobes Infect20024215716411880047
  • BrayPGWardSAO’NeillPMQuinolines and artemisinin: chemistry, biology and historyCurr Top Microbiol Immunol200529533816265885
  • RobertABenoit-VicalFDechy-CabaretOMeunierBFrom classical antimalarial drugs to new compounds based on the mechanism of action of artemisininPure Appl Chem200173711731180
  • AguiarACRochaEMSouzaNBFrançaTCKrettliAUNew approaches in antimalarial drug discovery and development – a reviewMem Inst Oswaldo Cruz2012107783184523147137
  • LuoXDShenCCThe chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivativesMed Res Rev19877129523550324
  • BalintGAArtemisinin and its derivatives: an important new class of antimalarial agentsPharmacol Ther2001902–326126511578659
  • MeshnickSRArtemisinin: mechanisms of action, resistance and toxicityInt J Parasitol200232131655166012435450
  • LiuYCuiKLuWSynthesis and antimalarial activity of novel dihydro-artemisinin derivativesMolecules20111664527453821629181
  • KyleDETeja-IsavadharmPLiQLeoKPharmacokinetics and pharmacodynamics of qinghaosu derivatives: how do they impact on the choice of drug and the dosage regimens?Med Trop (Mars)1998583 Suppl3844
  • WhiteNJClinical pharmacokinetics and pharmacodynamics of artemisinin and derivativesTrans R Soc Trop Med Hyg199488Suppl 1S41S438053024
  • BethelDSeYLonCArtesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trialPLoS One201165e1928321603629
  • WhiteNJAssessment of the pharmacodynamic properties of antimalarial drugs in vivoAntimicrob Agents Chemother1997417141314229210658
  • GarnerPGravesPMThe benefits of artemisinin combination therapy for malaria extend beyond the individual patientPLoS Med200524e10515839750
  • A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC) (TRACII)UKUniversity of Oxford [updated December 2, 2015]. Available from: https://clinicaltrials.gov/ct2/show/NCT02453308Accessed September 8, 2016
  • ParkBKO’NeillPMMaggsJLPirmohamedMSafety assessment of peroxide antimalarials: clinical and chemical perspectivesBr J Clin Pharmacol19984665215299862239
  • TangYDongYVennerstromJLSynthetic peroxides as antimalarialsMed Res Rev200424442544815170591
  • CummingJNWangDParkSBShapiroTAPosnerGHDesign, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisininJ Med Chem19984169529649526569
  • OpsenicaDMŠolajaBAAntimalarial peroxides (review)J Serb Chem Soc2009741111551187
  • Medicines for Malaria Venture (MMV)Peroxide potential for malariaGenevaMMV Available from: http://www.mmv.org/sites/default/files/uploads/docs/publications/Accessed September 12, 2016
  • Medicines for Malaria Venture (MMV)MMV Project of the Year award – 2006GenevaMMV Available from: http://www.mmv.org/research-development/project-year-award/mmv-project-year-award-2006Accessed September 15, 2016
  • Medicines for Malaria Venture (MMV)MMV annual report 2015GenevaMMV Available from: http://www.mmv.org/newsroom/publications/annual-report-2015Accessed September 20, 2016
  • PoonsakdiPDevelopment of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugsActa Trop200489332934214744559
  • RamirezAPThomasAMWoerpelKAPreparation of bicyclic 1,2,4-trioxanes from γ,δ-unsaturated ketonesOrg Lett200911350751019132925
  • RubushDMMorgesMARoseBJThammDHRovisTAn asymmetric synthesis of 1,2,4-trioxane anticancer agents via desymmetrization of peroxyquinols through a Brønsted acid catalysis cascadeJ Am Chem Soc201213433135541355722871165
  • MottBTTripathiASieglerMAMooreCDSullivanDJPosnerGHSynthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugsJ Med Chem20135662630264123425037
  • WangXCreekDJSchiaffoCESpiroadamantyl 1,2,4-trioxolane, 1,2,4-trioxane, and 1,2,4-trioxepane pairs: relationship between peroxide bond iron(II) reactivity, heme alkylation efficiency, and antimalarial activityBioorg Med Chem Lett200919164542454519616946
  • DongYCholletJMatileHSpiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypesJ Med Chem20054854953496116033274
  • VennerstromJLFuHNEllisWYDispiro-1,2,4,5-tetraoxanes: a new class of antimalarial peroxidesJ Med Chem19923516302330271501229
  • VennerstromJLDongYAndersenSLSynthesis and antimalarial activity of sixteen dispiro-1,2,4,5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanesJ Med Chem200043142753275810893313
  • AmewuRKChadwickJHussainASynthesis and evaluation of the antimalarial, anticancer, and caspase 3 activities of tetraoxane dimersBioorg Med Chem Lett2003212373927397
  • DongYCreekDCholletJComparative antimalarial activities of six pairs of 1,2,4,5-tetraoxanes (peroxide dimers) and 1,2,4,5,7,8-hexaoxonanes (peroxide trimers)Antimicrob Agents Chemother20075183033303517485500
  • EllisGLAmewuRSabbaniRSTwo-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profilesJ Med Chem20085172170217718341274
  • KumarNSinghRRawatDSTetraoxanes: synthetic and medicinal chemistry perspectiveMed Res Rev201232358161022675731
  • OpsenicaIOpsenicaDSmithKSMilhousWKSolajaBAChemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane antimalarialsJ Med Chem20085172261226618330976
  • O’NeillPMAmewuRKNixonGLIdentification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA182) with superior properties to the semisynthetic artemisininsAngew Chem201049335693569720629058
  • SharmaDChetiaDRudrapalMDesign, synthesis and antimalarial activity of some new 2-hydroxy-1,4-naphthoquinone-4-hydroxyaniline hybrid mannich basesAsian J Chem2016284782788
  • MuregiFWIshihANext-generation antimalarial drugs: hybrid molecules as a new strategy in drug designDrug Dev Res2010711203221399701
  • WalshJJBellAHybrid drugs for malariaCurr Pharm Des200915252970298519754373
  • SashidharaKVAvulaSRPalnatiGRSynthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparumBioorg Med Chem2012221754555459
  • SashidharaKVKumarAKumarMSarkarJSinhaSSynthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agentsBioorg Med Chem Lett201020247205721121071221
  • ManoharSRajeshUCKhanSITekwaniBLRawatDSNovel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activityACS Med Chem Lett20123755555924900509
  • KumarASrivastavaKRaja KumarSPuriSKChauhanPMSynthesis of 9-anilinoacridine triazines as new class of hybrid antimalarial agentsBioorg Med Chem Lett200919246996699919879137
  • ChadwickJAmewuRKMartiFAntimalarial mannoxanes: hybrid antimalarial drugs with outstanding oral activity profiles and a potential dual mechanism of actionChem Med Chem2011681357136121692184
  • ChauhanSSSharmaMChauhanPMTrioxaquines: hybrid molecules for the treatment of malariaDrug News Perspect2010231063264621180649
  • PosnerGHMcRinerAJPaikIHAnticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodentsJ Med Chem20044751299130114971910
  • SinghCMalikaHPuriSKOrally active amino functionalized antimalarial 1,2,4-trioxanesBioorg Med Chem Lett200414245946214698181
  • SinghCMalikaHPuriSKSynthesis and antimalarial activity of a new series of trioxaquinesBioorg Med Chem Lett200412511771182
  • BascoLKDechy-CabaretONdoungaMMecheFSRobertAMeunierBIn vitro activities of DU-1102, a new trioxaquine derivative against Plasmodium falciparum isolatesAntimicrob Agents Chemother20014561886188811353644
  • Benoit-VicalFJoeLBerryATrioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytesAntimicrob Agents Chemother20075141463147217242150
  • LoupCJoeLBenoit-VicalFMeunierBTrioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquineAntimicrob Agents Chemother200751103768377017698628
  • SashidharaKVKumarADoddaRPCoumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial agentsBioorg Med Chem Lett201222123926393022607674
  • AraújoNCPBartonVJonesMSemi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugatesBioorg Med Chem Lett20091972038204319251414
  • OliveiraRNewtonASGuedesRCAn endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasitesChem Med Chem2013891528153623853126
  • EganTJHaemozoin (malaria pigment): a unique crystalline drug targetTargets200323115124
  • FoleyMTilleyLQuinoline antimalarials: mechanism of action and resistance and prospects for new agentsPharmacol Ther19987916067
  • EganTJMarquesHMThe role of haem in the activity of chloroquine and related antimalarial drugsCoord Chem Rev1999190–192493517
  • FoleyMTilleyLQuinoline antimalarials mechanisms of action and resistanceInt J Parasitol19972722312409088993
  • PaulMO’NeillPMPosnerGHA medicinal chemistry perspective on artemisinin and related endoperoxidesJ Med Chem200447122945296415163175
  • CummingJNPloypradithPPosnerGHAntimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of actionAdv Pharmacol199637253297
  • O’NeillPMBartonVEWardSAThe molecular mechanism of action of artemisinin-the debate continuesMolecules20101531705172120336009
  • GolenserJWaknineJHKrugliakMHuntNHGrauGECurrent perspectives on the mechanism of action of artemisininsInt J Parasitol200636141427144117005183
  • ZhangFGosserDKJrMeshnickSRHemin-catalyzed decomposition of artemisinin (qinghaosu)Biochem Pharmacol1992438180518091575774
  • KrungkraiSRYuthavongYThe antimalarial action on Plasmodium falciparum, qinghaosu and artesunate in combination with agents that modulate oxidative stressTrans R Soc Trop Med Hyg19878157107143329778
  • MeshnickSRYangYZLimaVKuypersFKamchonwongpaisanSYuthavongYIron-dependant free radical generation and the antimalarial artemisinin (qinghaosu)Antimicrob Agents Chemother1993375110811148517699